Rupal Galipeau, MBA, CMA, is a Senior Finance Director currently leading the Vaccines division at GSK since 2025. They have amassed significant finance experience, serving as Finance Director at Johnson & Johnson from 2018 to 2019 and holding several roles, including Senior Financial Analyst and Finance Manager, at various organizations. Prior to GSK, Rupal was the Senior Finance Director for US Brand Growth at Kenvue from 2024 to 2025. Rupal earned a Bachelor of Science in Finance and an MBA from Rutgers University, completing their undergraduate degree in 2009 and their graduate degree in 2014.
This person is not in the org chart
This person is not in any teams
This person is not in any offices